---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-060805"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T21:41:12.900384+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics raises ~$5.8M via 4.64M shares at $1.25/share, 25% premium to VWAP

## Summary
- Issued 4,640,000 common shares at $1.25 per share, a 25% premium to 30-day VWAP.
- Net proceeds of approximately $5.8 million after offering expenses.
- Transaction closed on May 14, 2024.
- Registration statement due by Aug 15, 2024; investor locked up until Nov 9, 2024.
- Investor agrees to vote shares in line with board recommendation through May 14, 2025.

## SEC filing metadata
- accession: 0000950170-24-060805
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017024060805/0000950170-24-060805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017024060805/inkt-20240513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-060805
- JSON: https://secwatch.observer/filing/0000950170-24-060805.json
- Plain text: https://secwatch.observer/filing/0000950170-24-060805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.